Medicamen Organics Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Medicamen Organics Ltd is ₹ 29.2 as of 06 May 15:30 . The p/e ratio of Medicamen Organics Ltd changed from 6.3 to 6.3 over 1 quarters. This represents a CAGR of 0.00% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 4 quarters. This represents a CAGR of -100.00% The market cap of Medicamen Organics Ltd changed from ₹ 25.39 crore to ₹ 25.39 crore over 1 quarters. This represents a CAGR of 0.00% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Revenue of Medicamen Organics Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 . The EBITDA of Medicamen Organics Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 . The Net Profit of Medicamen Organics Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 . The dividend payout of Medicamen Organics Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Medicamen Organics Ltd

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
The Company market product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Medicamen Organics Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Medicamen Organics Ltd or Sanofi India Ltd?

Market cap of Medicamen Organics Ltd is 34 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Medicamen Organics Ltd and Sanofi India Ltd?

The stock performance of Medicamen Organics Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Organics Ltd and Sanofi India Ltd?

As of May 6, 2026, the Medicamen Organics Ltd stock price is INR ₹29.2. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Medicamen Organics Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Medicamen Organics Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.